Novartis in Slovenia once again impresses with its HR excellence and wins the "Top Employer" certificate for the second time
Novartis in Slovenia has once again been awarded the prestigious international "Top Employer" certificate for one of the best employers at both the Slovenian and European levels by the Top Employers Institute, an independent international institution. The certificate is an outstanding confirmation of the HR excellence of Novartis in Slovenia and its continuous efforts to improve the working environment. The newly obtained certificate complements last year's title of the most reputable employer in Slovenia and strengthens the position of Novartis among the best employers in Slovenia.
Earlier this year, Novartis in Slovenia was awarded the "Top Employer Slovenia" and "Top Employer Europe" titles. The Top Employer certificate is designed for companies with excellent HR practices and employee development programs, and covers six HR domains consisting of 20 themes, such as People Strategy, Work Environment, Talent Acquisition, Learning, Well-being, Diversity & Inclusion and others.
The "Top Employer" certificate is an important confirmation of our long-standing efforts to improve the working environment, introduce advanced forms of work, and offer a wide range of unique opportunities for professional and career development in the international arena. We recognize that our associates are our essence and our empowered culture is what sets us apart from other employers. We are proud that our commitment to a progressive and personalized work environment is recognized internationally. I am particularly pleased that we have further improved our outstanding results compared to last year," said Robert Ljoljo, President of the Board of Management of Lek and Novartis Country President Slovenia.
Novartis in Slovenia stood out in competition with European companies in several areas
Novartis in Slovenia outperformed the average scores of comparable companies at the European level in almost all criteria assessed in the survey. The average score of Novartis in Slovenia was 92.2%, which is higher than the average score of the participating European companies, which was 85.5%. Novartis in Slovenia impressed the evaluators most in the areas of business strategy, leadership, performance monitoring, commitment, values, and ethics and integrity. In these areas, Novartis in Slovenia received the highest possible score (100%).
Novartis in Slovenia stood out from other comparable European companies in the areas of diversity and inclusion management (16% higher than the average score of comparable companies), leadership, sustainability management, performance monitoring, career development opportunities, wellbeing and engagement.
The result of years of work to improve the working environment
Novartis in Slovenia has been awarded the "Top Employer" certificate for the second year in a row and is the first and only pharmaceutical company in Slovenia to be awarded this title. The certificate is the result of many years of creating a progressive, supportive and inclusive work environment where every associate can unleash their talents and creativity. In addition, Novartis in Slovenia is continuously making investments to create the conditions for new, advanced forms of work with active work solutions.
The Choice with Responsibility working model, which allows associates to choose how, where and when they do their work, depending on the nature of their work, has been fully implemented in the past year. Together with the removal of the old hierarchical structure and the introduction of an empowered culture, their application is based on collaboration, listening and learning, enabling agility and innovation to deliver the breakthrough solutions needed to stand out in a challenging pharmaceutical market and fulfill their mission of caring for patients around the world.
Novartis in Slovenia – an attractive career choice for top talent
Novartis in Slovenia is one of Slovenia's most important employers, and its continued growth and strengthening of its role in the global market for innovative medicines, innovative biologics, biosimilars and generics with high added value requires that it is constantly in touch with top talent and potential associates. The company manages its human resources and recruits new talent through innovative HR initiatives such as the Regional BioCamp and the Novartis Career Breakfast, both of which have been awarded several times in the past. The latter was recently attended by around 300 Slovenian and international young talents and professionals from various fields.
Successful HR and talent management is key to recruiting new associates. In 2021, the company increased its workforce by more than 590, bringing the number of associates to almost 5,500. A positive recruitment trend is foreseen for the future.
The "Top Employer" certificate for the best employer complements the "Most Reputable Employer" title awarded by the MojeDelo.com job portal, which Novartis in Slovenia received last year. It was also awarded the LGBT Friendly Company certificate last year and has held the Family Friendly Company certificate since 2007.
Novartis is the leading provider of medicines in Slovenia, where Lek d.d.,Novartis Pharma Services Inc. and Sandoz d.d., operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high-quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role inNovartis' organizational structure, especially in the Novartis Operations,Global Drug Development and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees. Novartis invested in Slovenia morethan EUR 3 billion since 2003.
About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical needs. Our ambition is to be the world’s leading and most valued generics company. Our broad portfolio of high-quality medicines, covering all major therapeutic areas, accounted for 2021 sales of USD 9.6 billion.
About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 800 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108,000 people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Gregor Makuc
Communications & External Engagement
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
gregor.makuc@sandoz.com
